AstraZeneca to cut Medicaid drug costs under Trump deal
AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration. Announced Friday, the agreement involves AstraZeneca offering most-favored-nation pricing — matching the lowest prices in other developed nations.
(Associated Press, 2025-10-11T06:34:20Z)